Growth factor synthesis

Growth factor synthesis refers to the multi-step biological process by which cells produce and release signaling proteins that stimulate cellular growth, proliferation, and differentiation (Source: NIH). This process involves gene transcription, mRNA translation, and often complex post-translational modifications and secretory pathways. While essential for normal physiological functions such as wound healing, tissue repair, and embryonic development, the dysregulation of growth factor synthesis is a major contributor to various pathologies (Source: PubMed). In oncology, the over-synthesis of factors like Vascular Endothelial Growth Factor (VEGF) or Epidermal Growth Factor (EGF) facilitates tumor survival and angiogenesis. In fibrotic diseases, the excessive production of Transforming Growth Factor-beta (TGF-beta) leads to pathological scarring. Therapeutic interventions targeting this process, such as Pirfenidone or antisense oligonucleotides, work by reducing the overall levels of these proteins rather than blocking their receptors (Source: DrugBank). However, because Growth factor synthesis is a broad physiological mechanism involving many different molecules, it is not classified as a single therapeutic target but rather a biological process.

Other names

Growth factor productionGrowth factor expressionGrowth factor secretionGrowth factor regulation

Inhibition of growth factor gene transcription, mRNA translation, or protein secretion pathways.